Company: LNAI
Filing Date: 2025-02-19
Form Type: 8-K
Source: 0001731122-25-000248
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 8-K
Item: Item 4.02
Chunk 0
---
Item 4.02 Non-Reliance on Previously Issued
Financial Statements or a Related Audit Report or Completed Interim Review.

On February
18, 2025, the Audit Committee (the “ Audit Committee”) of the Board of Directors of Renovaro Inc. (the “ Company”),
based on the recommendation of the Company’s management, and after consultation with the Company’s independent registered
public accounting firm, concluded that the Company’s previously issued unaudited interim condensed consolidated financial statements
contained within the Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, as amended (the “Q3 2024 Form 10-Q”),
(ii) the Company’s previously issued audited consolidated financial statements contained within the Annual Report on Form 10-K for
the year ended June 30, 2024 (the “2024 Form 10-K”), and (iii) the Company’s previously issued unaudited interim
condensed consolidated financial statements within the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Q1
2025 Form 10-Q” and, together with the Q3 2024 Form 10-Q and the 2024 Form 10-K, the “ Prior Filings”) contained
material misstatements related to certain warrants which were exercised during the three months ended March 31, 2024, which had not been
appropriately reflected as a component of the change in fair value of the contingent consideration in the Prior Filings. Accordingly,
those financial statements should no longer be relied upon. Similarly, related reports filed with the Securities Exchange Commission,
press releases, shareholder communications, investor presentations or other communications describing relevant portions of the Prior Filings’
financial statements should no longer be relied upon